General Info

International Stem Cell Corporation, also known as ISCO, is a California-based company that develops human stem cells to eliminate the rejection of transplanted cells by patient s immune system. It manufactures clinical and research products for the treatment of diabetes and liver and retinal diseases. The company also specializes in regenerative medicine, cell availability and immune rejection. In addition, International Stem Cell Corporation provides several cell transplantation therapies. It also has the Scientific Advisory Board. The company has locations in California, Maryland and Russia. International Stem Cell Corporation is a parent company of Lifeline Cell Technology.